Login to Your Account

Death sentence for faking clinical trial data, warns China

By Carmen Ho
Staff Writer

Wednesday, April 19, 2017

HONG KONG – In a nationwide effort to combat clinical trial data fabrication, China’s Supreme People’s Court and the CFDA have simultaneously proposed new actions and regulatory changes.

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription